Global Chemotherapy Infusion Pumps Market growing at a CAGR of 5.2% from 2023 to 2030
Category : Medical Devices | Published Date : May 2023 | Type : Press Release
Key Market Overview
According to a recent report by Consegic Business Intelligence, the chemotherapy infusion pumps market is poised for strong expansion and is expected to reach USD 7,111.19 Million by 2030. The market, which was valued at USD 4,768.45 Million in 2022, is predicted to grow at a compound annual growth rate of 5.2% during the period 2023-2030.
The report highlights the increasing prevalence of various types of cancer diseases that are driving the demand for chemotherapy infusion pumps. Consegic Business Intelligence study also provides insights into the market's competitive landscape, market segmentation, regional outlook, and emerging technologies in the chemotherapy infusion pumps market.
Global Chemotherapy Infusion Pumps Market By Overview
The chemotherapy infusion pumps market is bifurcated into type and end-users. Based on type, the market is segmented into large volume pumps, syringe pumps, ambulatory infusion pumps, elastomeric pumps, and others. In 2022, the syringe pump segment dominate in the overall chemotherapy infusion pumps market. The end-user segment is categorized into hospitals, clinics, home care, and others. In 2022, the hospital segment accounted for the highest market share in the chemotherapy infusion pumps market.
Get Free SampleMarket Dynamics
Driver:
- Increasing incidences of cancer that highly requires efficient chemotherapy treatment are boosting the demand for chemotherapy infusion pumps.
Restraints:
- Adverse events associated with the use of chemotherapy infusion pumps leading to numerous injuries and deaths are likely to hinder the market growth
- The adverse effects of chemotherapy and the presence of alternative approaches are likely to hinder market growth.
Market Segmentation:
| Report Attributes | Report Details |
| By Type | Large Volume Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Elastomeric Pumps, and Others |
| By End-User | Hospitals, Clinics, Home Care, and Others |
| By Region | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Competitive Landscape :
The market is dominated by certain major companies such as BD, Micrel Medical Devices SA, and ICU Medical, Inc. have a strong market position in current market circumstances. Further, the chemotherapy infusion pumps market is expected to witness significant growth in the coming years due to the rising incidence of breast cancer that majorly involves chemotherapy treatment. The market players compete for a firm market position through mergers and acquisitions, product innovations, and business strategies. Thus, evolving research and developments are expected to help market players adopt innovative ways of product creation to cater to the growing needs of various end-use industries
- BD
- ICU Medical, Inc.
- Terumo Corporation
- B. Braun SE
- Baxter International, Inc.
- Fresenius SE & Co. KGaA
- vTitan Corporation Pvt Ltd
- Moog Inc.
- ZynoMed
- Micrel Medical Devices SA
